The Rare Disease Foundation announces a new partnership with the R. Howard Webster Foundation (Montreal) to increase capacity for funding microgrant research over the next four years, beginning in March 2016!
Research Grants for Rare Disease Research Available from National Organization for Rare Disorders (NORD)
Washington, D.C., July 15, 2015 - The National Organization for Rare Disorders (NORD), the leading independent, nonprofit organization committed to the identification, treatment, and cures of rare diseases, has announced the availability of new research grants to study rare diseases. The deadline to submit abstracts and letters of intent is July 31
NORD’s 2015 research grant funding is available for study of:
Alveolar Capillary Dysplasia – One (1) grant of up to $50,000, for scientific research studies and/or clinical research studies related to Alveolar Capillary Dysplasia (ACD).
Cat Eye Syndrome - One (1) grant of up to $30,000 for a clinical research study related to the diagnosis and/or treatment of Cat Eye Syndrome..
Creutzfeldt-Jakob Disease - One (1) grant of up to $40,000 for a clinical research study related to the…
Parents don't know where to turn when faced with a diagnosis of a very rare or unique condition. If a relevant disease-based organization exists, it may be national or international in scope and other affected families may live far away. The Rare Disease Foundation can help at a local day-to-day level. Our parents have found that they have much to offer each other, regardless of diagnosis.
The statistic of 1 in 12 (or 1 in 10) people being affected with a rare disease is often quoted but its basis is rarely explained. We believe the actual chance of someone being affected with a rare disease in their lifetime (called lifetime prevalence) cannot be determined as there are not enough people trained to diagnose rare diseases and some conditions are either too severe to be compatible with life or are quite mild so are missed. There are also a large number of rare diseases waiting to be described so any estimate is likely to be an underestimate. One could even say every disease is rare because the genome, environment and lived experience of each patient form a unique constellation. With these caveats in mind, we calculate the lifetime prevalence of rare diseases at between 1 in 12 and 1 in 13 by:
3. Adding the prevalence of major birth defects and intellectual disability in the population (5%, range for this estimate is 2.3% to 6%).
Many people tell us they do not think that 1 out of every 12 people they know has a rare disease. We believe our estimate does not match common experience because a lot of children with rare diseases do not survive and because a lot of people who have rare diseases look completely normal to the outside observer. MP/2014